Prevention of Angiotensin II-Mediated Renal Oxidative Stress, Inflammation, and Fibrosis by Angiotensin-Converting Enzyme 2

被引:179
|
作者
Zhong, JiuChang
Guo, Danny
Chen, Christopher B.
Wang, Wang [5 ]
Schuster, Manfred [2 ]
Loibner, Hans [2 ]
Penninger, Josef M. [3 ]
Scholey, James W. [4 ]
Kassiri, Zamaneh [5 ]
Oudit, Gavin Y. [1 ,5 ]
机构
[1] Univ Alberta, Mazankowski Alberta Heart Inst, Dept Med, Div Cardiol, Edmonton, AB T6G 2S2, Canada
[2] Apeiron Biol, Vienna, Austria
[3] Austrian Acad Sci, Inst Mol Biotechnol, A-1010 Vienna, Austria
[4] Univ Toronto, Dept Med, Div Nephrol, Toronto, ON, Canada
[5] Univ Alberta, Dept Physiol, Edmonton, AB T6G 2S2, Canada
基金
中国国家自然科学基金;
关键词
angiotensin I; hypertension I; renal fibrosis; signal transduction; CHRONIC KIDNEY-DISEASE; PROXIMAL TUBULAR CELLS; INDUCED HYPERTENSION; PATHOLOGICAL HYPERTROPHY; ACE2; INJURY; EXPRESSION; MICE; DYSFUNCTION; INHIBITION;
D O I
10.1161/HYPERTENSIONAHA.110.164244
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Angiotensin-converting enzyme 2 (ACE2) is a monocarboxypeptidase capable of metabolizing angiotensin (Ang) II into Ang 1 to 7. We hypothesized that ACE2 is a negative regulator of Ang II signaling and its adverse effects on the kidneys. Ang II infusion (1.5 mg/kg(-1)/d(-1)) for 4 days resulted in higher renal Ang II levels and increased nicotinamide adenine dinucleotide phosphate oxidase activity in ACE2 knockout (Ace2(-/y)) mice compared to wild-type mice. Expression of proinflammatory cytokines, interleukin-1 beta and chemokine (C-C motif) ligand 5, were increased in association with greater activation of extracellular-regulated kinase 1/2 and increase of protein kinase C-alpha levels. These changes were associated with increased expression of fibrosis-associated genes (alpha-smooth muscle actin, transforming growth factor-beta, procollagen type I alpha 1) and increased protein levels of collagen I with histological evidence of increased tubulointerstitial fibrosis. Ang II-infused wild-type mice were then treated with recombinant human ACE2 (2 mg/kg(-1)/d(-1), intraperitoneal). Daily treatment with recombinant human ACE2 reduced Ang II-induced pressor response and normalized renal Ang II levels and oxidative stress. These changes were associated with a suppression of Ang II-mediated activation of extracellular-regulated kinase 1/2 and protein kinase C pathway and Ang II-mediated renal fibrosis and T-lymphocyte-mediated inflammation. We conclude that loss of ACE2 enhances renal Ang II levels and Ang II-induced renal oxidative stress, resulting in greater renal injury, whereas recombinant human ACE2 prevents Ang II-induced hypertension, renal oxidative stress, and tubulointerstitial fibrosis. ACE2 is an important negative regulator of Ang II-induced renal disease and enhancing ACE2 action may have therapeutic potential for patients with kidney disease. (Hypertension. 2011;57:314-322.). Online Data Supplement
引用
收藏
页码:314 / U338
页数:18
相关论文
共 50 条
  • [1] Ginsenoside Rg3 Attenuates Angiotensin II-Mediated Renal Injury in Rats and Mice by Upregulating Angiotensin-Converting Enzyme 2 in the Renal Tissue
    Liu, Hui
    Jiang, Yichuan
    Li, Min
    Yu, Xiaofeng
    Sui, Dayun
    Fu, Li
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2019, 2019
  • [2] Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade
    P Dandona
    S Dhindsa
    H Ghanim
    A Chaudhuri
    Journal of Human Hypertension, 2007, 21 : 20 - 27
  • [3] Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade
    Dandona, P.
    Dhindsa, S.
    Ghanim, H.
    Chaudhuri, A.
    JOURNAL OF HUMAN HYPERTENSION, 2007, 21 (01) : 20 - 27
  • [4] Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2
    Ferrario, CM
    Jessup, J
    Chappell, MC
    Averill, DB
    Brosnihan, KB
    Tallant, EA
    Diz, DI
    Gallagher, PE
    CIRCULATION, 2005, 111 (20) : 2605 - 2610
  • [5] Brain angiotensin-converting enzymes: role of angiotensin-converting enzyme 2 in processing angiotensin II in mice
    Elased, Khalid M.
    Cunha, Tatiana Sousa
    Marcondes, Fernanda Klein
    Morris, Mariana
    EXPERIMENTAL PHYSIOLOGY, 2008, 93 (05) : 665 - 675
  • [6] Renal angiotensin-converting enzyme and angiotensin-converting enzyme 2 gender differences in fetal programmed hypertension
    Stone, Ryan
    Su, Yixin
    Rose, James C.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2011, 204 : S207 - S208
  • [7] Alterations in Circulatory and Renal Angiotensin-Converting Enzyme and Angiotensin-Converting Enzyme 2 in Fetal Programmed Hypertension
    Shaltout, Hossam A.
    Figueroa, Jorge P.
    Rose, James C.
    Diz, Debra I.
    Chappell, Mark C.
    HYPERTENSION, 2009, 53 (02) : 404 - 408
  • [8] Angiotensin-converting enzyme 2 and renal disease
    Williams, Vanessa R.
    Scholey, James W.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2018, 27 (01): : 35 - 41
  • [9] Targeting the Degradation of Angiotensin II With Recombinant Angiotensin-Converting Enzyme 2 Prevention of Angiotensin II-Dependent Hypertension
    Wysocki, Jan
    Ye, Minghao
    Rodriguez, Eva
    Gonzalez-Pacheco, Francisco R.
    Barrios, Clara
    Evora, Karla
    Schuster, Manfred
    Loibner, Hans
    Brosnihan, K. Bridget
    Ferrario, Carlos M.
    Penninger, Josef M.
    Batlle, Daniel
    HYPERTENSION, 2010, 55 (01) : 90 - U160
  • [10] Angiotensin converting enzyme 2 attenuates angiotensin II-mediated phosphorylation of MAP kinase and Akt in neurons
    Sriramula, Srinivas
    Pedersen, Kim Brint
    Lazartigues, Eric
    FASEB JOURNAL, 2012, 26